Autofluorescence and Infrared Retinal Imaging in patients and obligate carriers with Neuronal Ceroid Lipofuscinosis FAF in NCL

Ophthalmic Genetics

Volumn 30, Issue 4, 2009, Pages 190-198

  Kelly, John P ^a,b   Weiss, Avery H ^a,b   Rowell, Gus ^c   Seigel, Gail M ^d  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Heidelberg Engineering Inc   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

Fundus autofluorescence (FAF); Infra red (IR) imaging; Neuronal Ceroid Lipofuscinosis (NCL); Obligate carriers

Indexed keywords

ADULT; ARTICLE; AUTOFLUORESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; EYE PHOTOGRAPHY; FEMALE; FUNDUS AUTOFLUORESCENCE; HUMAN; INFRARED OCULOGRAPHY; MALE; NEURONAL CEROID LIPOFUSCINOSIS; OPTIC DISK; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA MACULOPATHY; SCANNING LASER OPHTHALMOSCOPE; VASOCONSTRICTION;

ADOLESCENT; ADULT; ATROPHY; CHILD; DIAGNOSTIC IMAGING; FEMALE; FLUORESCEIN ANGIOGRAPHY; FLUORESCENCE; HETEROZYGOTE; HUMANS; INFRARED RAYS; LIPOFUSCIN; MALE; MIDDLE AGED; NEURONAL CEROID-LIPOFUSCINOSES; OPHTHALMOSCOPY; RETINAL DEGENERATION; RETINAL PIGMENT EPITHELIUM; YOUNG ADULT;

EID: 70350454889     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.3109/13816810903258829     Document Type: Article

References (28)

1. Mole SE, Williams RE, Goebel HH. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 2005;6:107-126.
2. Siintola E, Lehesjoki AE, Mole SE. Molecular genetics of the NCLs-status and perspectives. Biochim Biophys Acta 2006;1762:857-864.
3. Haltia M. The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol 2003;62:1-13.
4. Kyttälä A, Lahtinen U, Braulke T, Hofmann SL. Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins. Biochim Biophys Acta 2006;1762:920-933.
5. Spalton DJ, Taylor DS, Sanders MD. Juvenile Batten's disease: An ophthalmological assessment of 26 patients. Br J Ophthalmol 1980;64:726-732.
6. Collins J, Holder GE, Herbert H, Adams GG. Batten disease: Features to facilitate early diagnosis. Br J Ophthalmol 2006;90:1119-1124.
7. Cooper JD. Moving towards therapies for juvenile Batten disease? Exp Neurol 2008;211:329-331.
8. Carpenter S. Morphological diagnosis and misdiagnosis in Batten-Kufs disease. Am J Genet Suppl 1988;5:85-91.
9. Goebel HH. The neuronal ceroid-lipofuscinoses. J Child Neurol 1995;10:424-437.
10. Hainsworth DP, Liu GT, Hamm CW, Katz ML. Funduscopic and angiographic appearance in the neuronal ceroid lipofuscinoses. Retina 2009 Mar; [epub ahead of print.].
11. Horiguchi M, Miyake Y. Batten Disease-deteriorating course of ocular findings. Jpn J Ophthalmology 1992;36:91-96.
12. Goebel H, Wisniewski K. Symposium: The neuronal ceroid lipofuscinoses (NCL)-a group of lysosomal storage diseases come of age. Introduction Brain Pathology 2004;14:59-60.
13. Weleber RG, Gupta N, Trzupek KM, et al. Electroretinographic and clinicopathologic correlations of retinal dysfunction in infantile neuronal ceroid lipofuscinosis (infantile Batten disease). Mol Genet Metab 2004;83(1-2):128-137.
14. Tyynelä J, Suopanki J, Baumann M, Haltia M. Sphingolipid activator proteins (SAPs) in neuronal ceroid lipofuscinoses (NCL). Neuropediatrics 1997;28:49-52.
15. Bensaoula T, Shibuya H, Katz ML, et al. Histopathologic and immunocytochemical analysis of the retina and ocular tissues in Batten disease. Ophthalmology 2000;107:1746-1753.
16. Bellmann C, Holz FG, Schapp O, et al. Topography of fundus autofluorescence with a new confocal scanning laser ophthalmoscope (German). Ophthalmologe 1997;94:385-391.
17. von Rückmann A, Fitzke FW, Bird AC. Distribution of pigment epithelium autofluorescence in retinal disease state recorded in vivo and its change over time. Graefes Arch Clin Exp Ophthalmol 1999;237:1-9.
18. Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci 1995;36:718-729.
19. Lois N, Halfyard AS, Bird AC, Fitzke FW. Quantitative evaluation of fundus autofluorescence imaged "in vivo" in eyes with retinal disease. Br J Ophthalmol 2000;84:741-745.
20. Lois N, Halfyard AS, Bird AC, et al. Fundus autofluorescence in Stargardt macular dystrophy-fundus flavimaculatus. Am J Ophthalmol 2004;138:55-63.
21. Wabbels B, Demmler A, Paunescu K, et al. Fundus autofluorescence in children and teenagers with hereditary retinal diseases. Graefes Arch Clin Exp Ophthalmol 2006;244:36-45.
22. Schmitz-Valckenberg S, Holz FG, Bird AC, Spaide RF. Fundus autofluorescence imaging: review and perspectives. Retina 2008;28:385-409.
23. Mantel I, Brantley MA Jr, Bellmann C, et al.Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence. Klin Monatsbl Augenheilkd 2004;221: 427-430.
24. Trieschmann M, Spital G, Lommatzsch A, et al. Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch Clin Exp Ophthalmol 2003;241:1006-1012.
25. Robson AG, Moreland JD, Pauleikhoff D, et al. Macular pigment density and distribution: Comparison of fundus autofluorescence with minimum motion photometry. Vision Res 2003;43:1765-1775.
26. Wing GL, Blanchard GC, Weiter JJ. The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. Invest Ophthalmol Vis Sci 1978;17:601-617.
27. Weale RA. Age and the transmittance of the human crystalline lens. J Physiol 1988;395:577-587.
28. Kurz-Levin MM, Halfyard AS, Bunce C, et al. Clinical variations in assessment of bull's-eye maculopathy. Arch Ophthalmol 2002;120:567-575.